Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolism Disorder, Lipid”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05256654
What this trial is testing

LY3561774 in Participants With Mixed Dyslipidemia

Who this might be right for
DyslipidemiasLipid Metabolism DisordersMetabolic Diseases+1 more
Eli Lilly and Company 205
Not applicableUnknownNCT01167205
What this trial is testing

Positive Effects of Haematococcus Astaxanthin on Oxidative Stress and Lipid Profile in Overweight and Obese Adults

Who this might be right for
HealthyOverweightObesity
Seoul National University Hospital 30
Not applicableStudy completedNCT04626570
What this trial is testing

Impact of a Phone-based Cognitive and Behavioral Therapy on Food Addiction in Patients With Severe or Morbid Obesity

Who this might be right for
ObesityFood Addiction
University Hospital, Tours 154
Early research (Phase 1)Study completedNCT01603186
What this trial is testing

Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed Condition

Who this might be right for
Fed
IPCA Laboratories Ltd. 54
Post-approval studies (Phase 4)Study completedNCT01588470
What this trial is testing

Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 DiabetesCoronary Heart Disease
The University of Texas Health Science Center at San Antonio 130
Not applicableStudy completedNCT01087086
What this trial is testing

Reduction of the Metabolic Syndrome in Navarra-Spain

Who this might be right for
Metabolic SyndromeObesityDiabetes+1 more
Clinica Universidad de Navarra, Universidad de Navarra 109
Early research (Phase 1)Study completedNCT01437059
What this trial is testing

Trial to Evaluate Safety and Tolerability of ALN-PCS02 in Subjects With Elevated LDL-Cholesterol (LDL-C)

Who this might be right for
Elevated LDL-Cholesterol (LDL-C)
Alnylam Pharmaceuticals 32
Large-scale testing (Phase 3)Study completedNCT00134173
What this trial is testing

A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease

Who this might be right for
Coronary DiseaseCoronary ArteriosclerosisHyperlipidemia
Pfizer 1,100
Not applicableStudy completedNCT03173495
What this trial is testing

Effects of Exercise on Fructose-induced Postprandial Lipemia

Who this might be right for
Sedentary LifestyleDyslipidemiasLipid Metabolism Disorders+1 more
Federal University of Rio Grande do Sul 12
Post-approval studies (Phase 4)Study completedNCT02948777
What this trial is testing

Effects of PCSK9 Inhibition by Evolocumab on Postprandial Lipid Metabolism in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Marja-Riitta Taskinen 14
Large-scale testing (Phase 3)Study completedNCT02585895
What this trial is testing

Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment

Who this might be right for
Hypercholesterolemia
Amgen 39
Not applicableLooking for participantsNCT06953232
What this trial is testing

Acute Impact of Whey Protein-enriched Milk Fat Globule Membrane Supplementation on Postprandial Markers of Heart and Brain Health

Who this might be right for
Cardiovascular DiseasesCognitionOverweight or Obesity+2 more
Loughborough University 16
Not applicableStudy completedNCT01721187
What this trial is testing

Satiety Effects on the Neural Valuation of Food

Who this might be right for
FastingFed
Duke-NUS Graduate Medical School 60
Testing effectiveness (Phase 2)Ended earlyNCT03746587
What this trial is testing

Study of Arimoclomol in Patients Diagnosed With Gaucher Disease Type 1 or 3

Who this might be right for
Gaucher Disease, Type 1Gaucher Disease, Type 3
ZevraDenmark 39
Testing effectiveness (Phase 2)UnknownNCT00004293
What this trial is testing

Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease

Who this might be right for
Gaucher's Disease
National Center for Research Resources (NCRR) 24
Testing effectiveness (Phase 2)Study completedNCT02489344
What this trial is testing

Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease

Who this might be right for
Fabry Disease
Genzyme, a Sanofi Company 8
Not applicableStudy completedNCT04281537
What this trial is testing

Describe the Experience of Both Patients and Their Clinicians in the Treatment of Fabry Disease With Enzyme Replacement Therapy.

Who this might be right for
Fabry Disease
Amicus Therapeutics 82
Testing effectiveness (Phase 2)Study completedNCT03815812
What this trial is testing

Multiple Ascending Dose Study of PCSK-9 Inhibitor (IBI306) in Chinese Patients With Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
Innovent Biologics (Suzhou) Co. Ltd. 60
Not applicableUnknownNCT02705430
What this trial is testing

Effect of EPA-DHA Supplement, Life Style Modification Standard Treatment on Clinical Outcome Lipid Membrane Composition in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Rabin Medical Center 60
Large-scale testing (Phase 3)Study completedNCT01402128
What this trial is testing

Efficacy and Safety of Fermented Barley on Decrement of Body Fat in Obese Subjects

Who this might be right for
Overweight; Hyperlipidemia
Chonbuk National University Hospital 80
Next Page